English | Español
Patient Daily | Apr 24, 2026

BioSpace recognized for journalism covering biopharma changes during Trump administration
Patient Daily | Apr 24, 2026

Washington Post Opinion Editor on 340B drug discounts: 'The program has become a profit-making venture for big businesses'
Patient Daily | Apr 24, 2026

Steve Forbes on 340B program: Hospitals use it ‘to divert taxpayer-subsidized benefits for patients to unrelated interests’
Patient Daily | Apr 23, 2026

AAFA announces new resources for nasal polyps on Global CRSwNP Awareness Day
Patient Daily | Apr 23, 2026

Experts discuss advancements in diabetes management on Denatured podcast
Patient Daily | Apr 23, 2026

BioSpace report finds persistent gender and racial pay gaps in life sciences industry
Patient Daily | Apr 23, 2026

Health policy advocate raises concerns about 340B program's impact on patients
Patient Daily | Apr 23, 2026

Taxpayers Protection Alliance director says 340B program raises costs for patients and taxpayers

Trending
Patient Daily | Apr 23, 2026

Taxpayers Protection Alliance director says 340B program raises costs for patients and taxpayers
+ Pharmaceuticals
Patient Daily | Apr 19, 2026

Roche and C4 Therapeutics announce new molecular glue partnership worth up to $1 billion
+ Pharmaceuticals
Patient Daily | Apr 23, 2026

Bristol Myers Squibb spinout Beeline Medicines launches with $300 million and five assets
+ Pharmaceuticals
Patient Daily | Apr 19, 2026

Insmed ends skin disease drug development after trial results fall short